SCHEMBL30280216

SCHEMBL30280216

CON(C)C(=O)[C@@H](C)O[C@@H](C)C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.34
MLYCD O95822 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30280001 1.00 FAAH (0.34) FAAHMLYCD
SCHEMBL25168364 0.81
SCHEMBL29183039 0.73 FAAH (0.41) FAAH
SCHEMBL30280286 0.73 MLYCD (0.34) FAAHMLYCD
SCHEMBL20646017 0.72 MLYCD (0.35) FAAHMLYCD
SCHEMBL20854960 0.72 MLYCD (0.35) FAAHMLYCD
SCHEMBL30280181 0.71 TP53 (0.33)
SCHEMBL30322909 0.71 TP53 (0.33)
SCHEMBL3974169 0.71 TP53 (0.33)
SCHEMBL30280302 0.71 TP53 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4408837-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE IL-17 INHIBITOR COMPOUNDS JANSSEN Pharmaceutica NV (BE) 2024-08-07 EP disclosed
EP-4408847-A1 IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS Janssen Pharmaceutica NV (BE) 2024-08-07 EP disclosed
WO-2023049887-A1 IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2023-03-30 WO disclosed
WO-2023049885-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE IL-17 INHIBITOR COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2023-03-30 WO disclosed